Inadequate suspension of neutral protamine Hagendorn (NPH) insulin in pens
Authors:
- Peter M JehlePJPeter M Jehle
- Clemens MichelerCMClemens Micheler
- Daniela R JehleDJDaniela R Jehle
- Dieter BreitigDBDieter Breitig
- Bernhard O BoehmBBBernhard O Boehm
- 1 November 1999
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 354 (9190) , 1604-1607
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- The Kinetics of Insulin Administration by Insulin PensHormone and Metabolic Research, 1994
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- The Effect of Long-Term Intensified Insulin Treatment on the Development of Microvascular Complications of Diabetes MellitusNew England Journal of Medicine, 1993
- Use of the pen delivery system for intensive insulin therapy in college-age students with type I diabetesJournal of Adolescent Health, 1991
- Long term efficacy of a pen injectorIrish Journal of Medical Science (1971 -), 1991
- Deterioration in Blood Glucose Control in Females with Diabetes Changed to a Basal‐bolus Regimen Using a Pen‐injectorDiabetic Medicine, 1991
- THE INSULIN PENThe Lancet, 1989
- A Randomized Trial of the Efficacy and Acceptability of a Pen InjectorDiabetic Medicine, 1988
- NPH Insulin Administration by Means of a Pen InjectorDiabetic Medicine, 1988